RE:RE:RE:RE:RE:RE:This has some people very nervous:"You are being conned by the con-man Gilles Gagnon.
All of the 'facts' you cite as coming from Symrise actually come from Gagnon!!"
We do know for certain that Symrise last year complemented the long standing Symrise/CZO product development relationship. Symrise saw its partnership with CZO of "great value" and said it expected it to continue to "pave the way for future developments". Symrise looks excited both about its work with CZO to date and its future. It looks like a satisfied customer. Canadian pharma icon Ronnie Miller has joined CZO's team too last year. CZO has added a CRO to map out the future. The next round of PGX scale-up has been given a green light and CZO doesn't have to invest in it if it doesn't want to. The CoQ10 bioavailability results at the University of Alberta blew the gold standard out of the water. PGX-YBG and PGX-Alginate have demonstrated unique results. Based on all of the evidence it wouldn't surprise me if Symrise is very interested in PGX product development in the future. It makes sense.
“Ceapro and Symrise have a long-standing relationship in product development that has benefitted both companies over the years,” said Joern Andreas, President Cosmetic Ingredients Division, Symrise AG. “We see great value in this partnership and are very pleased to have secured this agreement, which will continue to pave the way for future developments that I believe will benefit both companies in creating value.” News release